Literature DB >> 8734496

Xenopus Xsal-1, a vertebrate homolog of the region specific homeotic gene spalt of Drosophila.

T Hollemann1, R Schuh, T Pieler, R Stick.   

Abstract

We have isolated an amphibian homolog of the homeotic gene spalt of Drosophila. Like its Drosophila counterpart the Xenopus Xsal-1 gene encodes a protein that contains three widely separated sets of sequence related double zinc finger motifs of the CC/HH-type as well as a single CC/HH zinc finger. The Xenopus gene encodes a fourth double zinc finger and a single CC/HC zinc finger motif that have no counterpart in the fly protein. Alternative splicing of Xsal-1 transcripts gives rise to RNAs coding for either four, three or two double zinc fingers, respectively. The main expression domains of Xsal-1 in early development are confined to distinct regions along the lateral axon tracts within the midbrain, hindbrain, and spinal cord. Outside the central nervous system Xsal-1 is expressed in the facio-acoustic ganglion and in the developing limb buds. The pattern of expression suggests that Xsal-1 might be under control of signals emanating from the notochord and/or the floor plate and that it might function in neuronal cell specification.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8734496     DOI: 10.1016/0925-4773(95)00485-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  17 in total

1.  Heat shock 70-kDa protein 5 (Hspa5) is essential for pronephros formation by mediating retinoic acid signaling.

Authors:  Weili Shi; Gang Xu; Chengdong Wang; Steven M Sperber; Yonglong Chen; Qin Zhou; Yi Deng; Hui Zhao
Journal:  J Biol Chem       Date:  2014-11-14       Impact factor: 5.157

2.  The role of HSAL (SALL) genes in proliferation and differentiation in normal hematopoiesis and leukemogenesis.

Authors:  Li Chai
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

3.  Mutations at the SALL4 locus on chromosome 20 result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, acro-renal-ocular syndrome, and patients previously reported to represent thalidomide embryopathy.

Authors:  J Kohlhase; L Schubert; M Liebers; A Rauch; K Becker; S N Mohammed; R Newbury-Ecob; W Reardon
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

Review 4.  Kidney regeneration: common themes from the embryo to the adult.

Authors:  M Cecilia Cirio; Eric D de Groh; Mark P de Caestecker; Alan J Davidson; Neil A Hukriede
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

5.  Induction of ectopic olfactory structures and bone morphogenetic protein inhibition by Rossy, a group XII secreted phospholipase A2.

Authors:  Ignacio Muñoz-Sanjuán; Ali H Brivanlou
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Developmental expression of Xenopus short-chain dehydrogenase/reductase 3.

Authors:  Richard K T Kam; Yonglong Chen; Sun-On Chan; Wood-Yee Chan; Igor B Dawid; Hui Zhao
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 7.  The role of stem cell factor SALL4 in leukemogenesis.

Authors:  Chong Gao; Nikki R Kong; Li Chai
Journal:  Crit Rev Oncog       Date:  2011

8.  Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex.

Authors:  Chong Gao; Todor Dimitrov; Kol Jia Yong; Hiro Tatetsu; Ha-won Jeong; Hongbo R Luo; James E Bradner; Daniel G Tenen; Li Chai
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

9.  Regionalized metabolic activity establishes boundaries of retinoic acid signalling.

Authors:  T Hollemann; Y Chen; H Grunz; T Pieler
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

10.  Loss of the Sall3 gene leads to palate deficiency, abnormalities in cranial nerves, and perinatal lethality.

Authors:  M Parrish; T Ott; C Lance-Jones; G Schuetz; A Schwaeger-Nickolenko; A P Monaghan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.